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• The extent of lymphocyte depletion after radiation as well as the duration and possible associated excess risk of infection from lymphopenia are unknown.
Aim of the Study
• To examine the kinetics of lymphocyte counts before and after radiotherapy; and its association with the long term risk of infection.
• General characteristics for 14,823 patients included in the study are described in Table 2 .
• Lymphocyte counts declined in the first month after initiation of radiotherapy, median 0.60 (0.37-1.00) cells/µL, then increased gradually during follow-up.
• At month 24, 28.6% of cohort under follow-up had lymphopenia (Figure 2 ).
• During 39,620 person-years of follow-up, 3,644 (24.6%) patients had at least one hospital admission with a diagnosis of infection.
• Respiratory tract infections accounted for almost 50% of the infectious diagnoses (Figure 3 ). • Lymphopenia before radiotherapy; and 6, 12 and 24 months after radiotherapy start was associated with increased risk of subsequent hospital admission with a diagnosis of infection ( Table 3 ).
• The cohort constitutes patients who received a first course of radiotherapy in the period 2005-2016 at Copenhagen University Hospital.
• Lymphocyte counts were identified at pre-defined time points according to radiotherapy start ( Table 1 ).
• Patients contributing with a lymphocyte count in at least one of the pre-defined time points were included in the analysis (Figure 1 ).
• Lymphopenia was defined as a lymphocyte count < 1.0 x 10 3 cells/µL.
• Risk of infection was defined as the time to first hospital admission with a diagnosis of infection, according to ICD-10 codes.
Statistical Analysis
• Association between lymphopenia at pre-defined time points and incidence of first hospital admission with an infection was assessed by Poisson regression analysis, adjusted for age, sex and calendar year.
• Follow-up started at each time-point and it was censored when either outcome, death or 1 January 2017 was reached.
BACKGROUND METHODS

RESULTS
CONCLUSIONS
• The majority of cancer patients appear to develop lymphopenia shortly after radiotherapy has been initiated; and for some, this persist for at least 24 months thereafter.
• Lymphopenia just prior to and after radiotherapy is associated with increased risk of subsequent hospital admission with an infection.
PERSPECTIVES
